key: cord-0838674-yp3ufwbt
authors: Mohamed, Mouhand F. H.
title: Caution Is Needed When Reporting or Pooling the Prevalence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients
date: 2020-10-19
journal: Crit Care Med
DOI: 10.1097/ccm.0000000000004693
sha: c7f6b1401c6dd5ff9ba4c8e8463bccfe7ca4dcbc
doc_id: 838674
cord_uid: yp3ufwbt

nan

. Multicompartimental model showed the relationship among intracranial pressure (ICP), ITP, and intra-abdominal pressure (IAP). ARDS = acute respiratory distress syndrome, BPP = brain parenchyma pressure, CBV = cerebral blood volume, CPP = cerebral perfusion pressure, CSF = cerebrospinal fluid, CSFP = cerebrospinal fluid pressure, MABP = mean arterial blood pressure, PEEP = positive end expiratory pressure, VP = vascular pressure. Printed with permission from Godoy et al (4 general, to inaccurate reporting of VTE prevalence in individual studies and pooling in meta-analyses.

Trigonis et al (1) included patients who underwent LLUS. Patients in ICU undergo LLUS generally when deep venous thrombosis (DVT) is suspected (except when systematic screening is part of a study protocol) (2) . This indicates that the prevalence provided by studies looking at a group of patients who underwent diagnostic imaging may not represent the prevalence of the whole ICU cohort, instead a selected high-risk group. This prevalence helps the clinician understand the proportion of positive LLUS once DVT is suspected, and a test is requested. Similarly, studies exploring pulmonary embolism (PE) prevalence by examining CT pulmonary angiography (CTPA) scans report PE in a selected group of patients who had PE suspicion and underwent imaging (3). This helps both the physician ordering the CTPA and the radiologist who interprets CTPA understanding the proportion of positive CT scans once a CTPA is ordered. Nonetheless, it does not represent PE prevalence in the whole ICU cohort. Misinterpreting this has led to an inflation of the prevalence of PE events in the general coronavirus disease 2019 (COVID-19) population in the initial phase of the COVID-19 pandemic and the notion that PE prevalence is higher than DVT in critically ill COVID-19 patients (4) . Additionally, it led to perhaps inaccuracies in the pooled incidence of VTE reported by several meta-analyses (5) .

When systematic screening is adopted to screen for VTE in all ICU cohorts, the prevalence of DVT was as high as 85% (2) . This may explain the VTE prevalence discrepancy between the studies that do not adopt systematic screening and studies that adopt it. It also shows that our clinical ability to predict and diagnose VTE is far from optimal. Wichmann et al (6) reported 58% undiagnosed VTE prevalence in 12 COVID-19 patient's autopsies. This suggests that studies with high mortality could report a spuriously low VTE prevalence when systematic screening or autopsies are not attempted. Furthermore, as inferred from the study by Wichmann et al (6) , VTE events may have been an overlooked cause of mortality in this cohort.

Statistically, the exact VTE incidence, incidence rate, or prevalence is generally difficult to ascertain in ICU settings. This is due to various reasons, including the absence of uniform screening at ICU admission to exclude patients with prior VTE, absence of systematic assessment with varying screening guided by clinicians' suspicion, and varying follow-up time. Finally, this letter aimed to improve the understanding of the VTE burden in critically ill patients. Notwithstanding this, the burden is high. Efforts are needed to improve the prevention, screening, and diagnosis of VTE in this patient cohort.

I thank the editor for the timely review and feedback.

Dr. Mohamed conceived the idea of this letter, wrote the manuscript, and submitted it for publication.

The author has disclosed that he does not have any potential conflicts of interest.

Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease

Patients Receiving Prophylactic Anticoagulation

Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan

Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels

Lille ICU Haemostasis COVID-19 Group: Pulmonary embolism in COVID-19 patients: Awareness of an increased prevalence

Incidence and mortality of pulmonary embolism in COVID-19: A systematic review and meta-analysis

Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study